Over 40 manufacturing partner companies in North America, Europe, and Asia

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. The company maintains a vast portfolio of more than 1,400 approved molecules across a wide range of therapeutic areas, including non-communicable and infectious diseases. Viatris operates a complex global supply chain, utilizing approximately 40 of its own manufacturing facilities alongside a network of over 40 external manufacturing partner companies across North America, Europe, and Asia. The company focuses on providing access to medicines, including generics, complex generics, biosimilars, and iconic brand-name products like Lipitor and Viagra.